HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nintedanib inhibits TGF-β-induced myofibroblast transdifferentiation in human Tenon's fibroblasts.

AbstractPurpose:
This study aimed to investigate the effect of nintedanib on the conversion of human Tenon's fibroblasts (HTFs) into myofibroblasts and reveal the molecular mechanisms involved.
Methods:
Primary cultured HTFs were incubated with transforming growth factor β1 (TGF-β1) alone or combined with nintedanib, and cell proliferation and migration were measured by cell counting kit-8 (CCK8) and the scratch wound assay, respectively. HTF contractility was evaluated with a 3D collagen contraction assay. The mRNA and protein levels of α smooth muscle actin (α-SMA) and Snail and the phosphorylation levels of Smad2/3, p38 mitogen-activated protein kinase (p38MAPK), and extracellular signal-regulated kinase ½ (ERK1/2) were determined by quantitative reverse transcription polymerase chain reaction (RT-PCR), western blot, and immunofluorescence staining.
Results:
Nintedanib inhibited the proliferation and migration of HTFs in a dose-dependent manner. Furthermore, nintedanib prevented HTF myofibroblast differentiation via downregulation of mRNA and protein expression of α-SMA and Snail. A three-dimensional (3D) collagen gel contraction assay demonstrated that nintedanib effectively inhibits myofibroblast contraction induced by TGF-β1. Mechanistically, we revealed that nintedanib reduces the TGF-β1-induced phosphorylation of Smad2/3, p38MAPK, and ERK1/2, suggesting that nintedanib acts through both classic and nonclassic signaling pathways of TGF-β1 to prevent HTF activation.
Conclusions:
Our study provides new evidence that nintedanib has potent antifibrotic effects in HTFs and suggests that it may be used as a potential therapeutic agent for subconjunctival fibrosis.
AuthorsXianchai Lin, Jiamin Wen, Rongjiao Liu, Wuyou Gao, Bo Qu, Minbin Yu
JournalMolecular vision (Mol Vis) Vol. 24 Pg. 789-800 ( 2018) ISSN: 1090-0535 [Electronic] United States
PMID30636861 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ACTA2 protein, human
  • Actins
  • Indoles
  • SMAD2 protein, human
  • SMAD3 protein, human
  • SNAI1 protein, human
  • Smad2 Protein
  • Smad3 Protein
  • Snail Family Transcription Factors
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • p38 Mitogen-Activated Protein Kinases
  • nintedanib
Topics
  • Actins (antagonists & inhibitors, genetics, metabolism)
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Cell Transdifferentiation (drug effects)
  • Dose-Response Relationship, Drug
  • Fibroblasts (cytology, drug effects, metabolism)
  • Gene Expression Regulation (drug effects)
  • Humans
  • Indoles (pharmacology)
  • Mitogen-Activated Protein Kinase 1 (genetics, metabolism)
  • Mitogen-Activated Protein Kinase 3 (genetics, metabolism)
  • Myofibroblasts (cytology, drug effects, metabolism)
  • Phosphorylation (drug effects)
  • Primary Cell Culture
  • Signal Transduction (drug effects, genetics)
  • Smad2 Protein (genetics, metabolism)
  • Smad3 Protein (genetics, metabolism)
  • Snail Family Transcription Factors (antagonists & inhibitors, genetics, metabolism)
  • Tenon Capsule (cytology, metabolism)
  • Transforming Growth Factor beta1 (antagonists & inhibitors, pharmacology)
  • p38 Mitogen-Activated Protein Kinases (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: